Faron Pharmaceuticals Oy (LON:FARN) Reaches New 1-Year Low at $120.00

Shares of Faron Pharmaceuticals Oy (LON:FARN) hit a new 52-week low during trading on Wednesday . The company traded as low as GBX 120 ($1.49) and last traded at GBX 120 ($1.49), with a volume of 38147 shares. The stock had previously closed at GBX 125 ($1.56).

Faron Pharmaceuticals Oy Price Performance

The business’s 50 day moving average price is GBX 155.30 and its 200 day moving average price is GBX 244.45. The stock has a market capitalization of £81.37 million, a P/E ratio of -269.05 and a beta of -0.14. The company has a debt-to-equity ratio of 121.51, a current ratio of 0.59 and a quick ratio of 1.09.

Faron Pharmaceuticals Oy Company Profile

Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, acute kidney injury, cardiac protection, solid organ transplant, and ischemia reperfusion injury; and Bexmarilimab, a novel precision cancer immunotherapy candidate for treating solid tumors, non-small cell lung carcinoma, and hematological malignancies.